Last updated on November 2017

ABSORB III - Randomized Controlled Trial


Brief description of study

ABSORB III - Randomized Controlled Trial

Detailed Study Description

A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Clinical Study Identifier: TX81173

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Robin L. Buckner

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »